Get started
NOVAVAX INCNOVAVAX INCNOVAVAX INC

NOVAVAX INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

NVAX chart


Full chart

Key facts today


Novavax shares surged 17.1% to $7.32 after the FDA sought more clinical data for its COVID-19 vaccine. The stock rose 13% in premarket trading, reflecting positive FDA discussions.
Analyze the impactAnalyze the impact

NVAX upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪850.74 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.182 EUR
Net income (FY)
‪−181.12 M‬ EUR
Revenue (FY)
‪658.95 M‬ EUR
Shares float
‪146.58 M‬
Beta (1Y)
1.69

Employees


Employees (FY)
952
Change (1Y)
−591 −38.30%
Revenue / Employee (1Y)
‪692.18 K‬ EUR
Net income / Employee (1Y)
‪−190.25 K‬ EUR

About Novavax, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
John C.s Jacobs
Website
novavax.com
Headquarters
Gaithersburg
Founded
1987
FIGI
BBG01Q6C2B10
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

NVAX news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

NVAX highest yielding bonds


NVAX5729297
Novavax, Inc. 5.0% 15-DEC-2027
Yield to maturity
9.23%
Maturity date
Dec 15, 2027

See all NVAX bonds 

Sparks


Curated watchlists where NVAX is featured.

See all sparks 


Check out other big names from the same industry as NVAX.

Frequently Asked Questions


The current price of NVAX is 6.470 EUR — it has increased by 2.31% in the past 24 hours. Watch NOVAVAX INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on VIE exchange NOVAVAX INC stocks are traded under the ticker NVAX.
NVAX stock has fallen by −5.27% compared to the previous week, the month change is a −23.98% fall, over the last year NOVAVAX INC has showed a −41.69% decrease.
We've gathered analysts' opinions on NOVAVAX INC future price: according to them, NVAX price has a max estimate of 22.34 EUR and a min estimate of 8.04 EUR. Watch NVAX chart and read a more detailed NOVAVAX INC stock forecast: see what analysts think of NOVAVAX INC and suggest that you do with its stocks.
NVAX reached its all-time high on Oct 4, 2024 with the price of 13.350 EUR, and its all-time low was 4.706 EUR and was reached on Apr 10, 2025. View more price dynamics on NVAX chart.
See other stocks reaching their highest and lowest prices.
NVAX stock is 20.58% volatile and has beta coefficient of 1.69. Track NOVAVAX INC stock price on the chart and check out the list of the most volatile stocks — is NOVAVAX INC there?
Today NOVAVAX INC has the market capitalization of ‪884.71 M‬, it has increased by 2.10% over the last week.
Yes, you can track NOVAVAX INC financials in yearly and quarterly reports right on TradingView.
NOVAVAX INC is going to release the next earnings report on May 7, 2025. Keep track of upcoming events with our Earnings Calendar.
NVAX earnings for the last quarter are −0.49 EUR per share, whereas the estimation was −0.50 EUR resulting in a 0.78% surprise. The estimated earnings for the next quarter are 0.17 EUR per share. See more details about NOVAVAX INC earnings.
NOVAVAX INC revenue for the last quarter amounts to ‪85.31 M‬ EUR, despite the estimated figure of ‪81.51 M‬ EUR. In the next quarter, revenue is expected to reach ‪188.64 M‬ EUR.
NVAX net income for the last quarter is ‪−78.27 M‬ EUR, while the quarter before that showed ‪−108.94 M‬ EUR of net income which accounts for 28.15% change. Track more NOVAVAX INC financial stats to get the full picture.
No, NVAX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 24, 2025, the company has 952 employees. See our rating of the largest employees — is NOVAVAX INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVAVAX INC EBITDA is ‪−177.20 M‬ EUR, and current EBITDA margin is −26.90%. See more stats in NOVAVAX INC financial statements.
Like other stocks, NVAX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVAVAX INC stock right from TradingView charts — choose your broker and connect to your account.